HLA-DOA anticorps (AA 26-135)
Aperçu rapide pour HLA-DOA anticorps (AA 26-135) (ABIN7155580)
Antigène
Voir toutes HLA-DOA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 26-135
-
Réactivité croisée
- Humain
-
Purification
- Antigen Affinity Purified
-
Immunogène
- Recombinant Human HLA class II histocompatibility antigen, DO alpha chain protein (26-135AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- HLA-DOA (HLA Class II DO alpha (HLA-DOA))
-
Autre désignation
- HLA-DOA
-
Sujet
-
Background: Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.
Aliases: HLA-DOA antibody, HLA-DNA antibody, HLA-DZAHLA class II histocompatibility antigen antibody, DO alpha chain antibody, MHC DN-alpha antibody, MHC DZ alpha antibody, MHC class II antigen DOA antibody
-
UniProt
- P06340
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Antigène
-